FDA Approved: DALFAMPRIDINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories, LLC's supplemental application for dalfampridine (generic) under ANDA206765.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)